Advertisement
Research Article

The Economic Benefits Resulting from the First 8 Years of the Global Programme to Eliminate Lymphatic Filariasis (2000–2007)

  • Brian K. Chu mail,

    bchu@taskforce.org

    Affiliation: Lymphatic Filariasis Support Center, The Task Force for Global Health, Decatur, Georgia, United States of America

    X
  • Pamela J. Hooper,

    Affiliation: Lymphatic Filariasis Support Center, The Task Force for Global Health, Decatur, Georgia, United States of America

    X
  • Mark H. Bradley,

    Affiliation: Global Community Partnerships, GlaxoSmithKline, London, United Kingdom

    X
  • Deborah A. McFarland,

    Affiliation: Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America

    X
  • Eric A. Ottesen

    Affiliation: Lymphatic Filariasis Support Center, The Task Force for Global Health, Decatur, Georgia, United States of America

    X
  • Published: June 01, 2010
  • DOI: 10.1371/journal.pntd.0000708

About the Authors

Brian K. Chu, Pamela J. Hooper, Eric A. Ottesen
Lymphatic Filariasis Support Center, The Task Force for Global Health, Decatur, Georgia, United States of America
Mark H. Bradley
Global Community Partnerships, GlaxoSmithKline, London, United Kingdom
Deborah A. McFarland
Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America

Corresponding Author

Email: bchu@taskforce.org

Competing Interests

MHB currently works for GlaxoSmithKline.

Author Contributions

Conceived and designed the experiments: BKC PJH MHB DAM EAO. Performed the experiments: BKC PJH MHB DAM EAO. Analyzed the data: BKC PJH MHB DAM EAO. Wrote the paper: BKC PJH MHB DAM EAO.